Tongmai Jiangtang capsule for heart risks in metabolic syndrome
Part of Brain & nervous system, Heart & circulation, Hormones & metabolism clinical trials.
This trial tests whether the Tongmai Jiangtang capsule can reduce serious heart and stroke problems in older adults with metabolic syndrome who are also at high risk for heart disease. It focuses on people with a specific traditional Chinese medicine pattern called Qi-deficiency and Blood Stasis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 65 years or older.
- You must have metabolic syndrome, which means having at least 3 of these: a large waist (men 90 cm or more, women 85 cm or more), high blood sugar, high blood pressure, high triglycerides, or low good cholesterol.
- You must have symptoms of Qi-deficiency and Blood Stasis, such as feeling tired, short of breath, having stabbing pain, bruising, or a purple tongue.
- You must be at high risk for heart problems, for example having had a heart attack, stroke, certain artery blockages, or heart failure.
- You cannot have Type 1 diabetes, severe heart failure, recent heart or stroke events (within 14 days), or certain other serious conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether taking Coenzyme Q10, a natural supplement, can improve heart health markers in people who have or are at high risk for metabolic syndrome. Metabolic syndrome is a group of conditions like high blood sugar, high blood pressure, and belly fat that raise your risk for heart disease and diabetes.
This trial studies how Maixuekang capsules are processed in the body of healthy adults. It looks at the drug's levels over time to make sure it works safely.
This trial tests whether Xuesaitong soft capsules can improve major risk factors in people with stable coronary heart disease who are already on cholesterol-lowering and antiplatelet medications. You may be able to join if you have chronic coronary artery disease and certain signs of inflammation.
This trial tests whether traditional Chinese medicine can help elderly patients with coronary heart disease who still have chest pain or discomfort despite standard treatments. It focuses on those who cannot have or have not fully benefited from procedures like stents or bypass surgery.
This trial tests a traditional Chinese herbal capsule (Linzhi Jianghuang Fufang) to treat non-alcoholic fatty liver disease—a buildup of fat in the liver not caused by alcohol. The study aims to see if this herbal treatment can safely reduce liver fat and improve metabolic health in people with early-stage fatty liver.
This trial tests if a traditional Chinese medicine, Tongxinluo, can help prevent the artery from narrowing again after a stent procedure in the brain or neck. It's for people who have had a stroke or are at risk and recently got a stent.
Hear when a new Metabolic Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.